U.S., June 16 -- ClinicalTrials.gov registry received information related to the study (NCT07648160) titled 'Contrast-enhanced CBCT With C-arm HyperSight Technology' on June 09.
Brief Summary: This is a single-arm prospective, feasibility study evaluating the intravenous contrast-enhanced cone beam computed tomography (IV CBCT) for image guidance during radiotherapy. Patients treated with SFRT will receive IV-contrast enhanced CT and fMRI before treatment for simulation purposes. Additionally, patients will receive mpMRI just before and IV-contrast enhanced CBCT during their second and last fraction of RT, in addition to the standard of care CBCT that is acquired for daily image-guided patient positioning. Patients will undergo both IV-con...